As the only real anesthetic agent for diagnostic and surgical treatments that don't have to have skeletal muscle mass relaxation. A method of ketamine known as esketamine nasal spray was approved with the FDA in 2019 under the title Spravato to be used in therapy-resistant depression. The drug is given https://bookmarksurl.com/story3514453/5-essential-elements-for-ketamine-nasal-spray